NanoDoce expanded access opens for urogenital cancer patients
NCT ID NCT04060628
First seen Jan 25, 2026 · Last updated May 15, 2026 · Updated 17 times
Summary
This program offered expanded access to NanoDoce for people with urogenital cancers who could not join ongoing clinical trials. It was designed to provide treatment outside of a formal study. The program is no longer available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROGENITAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.